|
(P1413) |
Advanced Registration for 3D CTA-XR Fusion during Transcatheter Aortic Valve Implantation (TAVI) |
|
|
I. Vernikouskaya, W. Rottbauer, J. Seeger, B. Gonska, V. Rasche, J. Wöhrle (Ulm) |
|
(P1414) |
Color paucity sign and basal leaflet thickening in the evaluation of subclinical leaflet thrombosis after TAVR: Correlation with high-resolution CT |
|
|
L. Bäz, M. Franz, S. Möbius-Winkler, U. Teichgräber, P. C. Schulze, A. Hamadanchi (Jena) |
|
(P1415) |
Neuron-specific enolase is associated with post-procedural stroke after transcatheter aortic valve implantation |
|
|
T. Keller, M. Renker, N. Staubach, M. Arsalan, S. Keranov, H. Nef, L. Gaede, H. Möllmann, C. Troidl, T. Walther, C. Liebetrau, C. W. Hamm, W.-K. Kim (Bad Nauheim, Gießen, Dortmund) |
|
(P1416) |
Impact of serum hemoglobin level at discharge on long-term survival in patients underwent transcatheter aortic valve implantation for severe aortic stenosis: An observational cohort. |
|
|
M. Okamoto, H. Kaneko, G. Tambor, M. Neuß, F. Hölschermann, C. Butter (Bernau bei Berlin) |
|
(P1417) |
Preoperative low serum albumin levels predict postoperative complications and mortality in patients undergoing Transcatheter Aortic Valve Replacement |
|
|
A. Gassa, J. H. Borghardt, S. Ney, K. Kuhr, J. Maier, T. K. Rudolph, S. Baldus, N. Madershahian, T. Wahlers (Köln) |
|
(P1418) |
Differential Prognostic Value of Galectin-3 after Transcatheter Aortic Valve Implantation According to Levels of CA125 |
|
|
T. Rheude, C. Pellegrini, J. Nunez, T. Trenkwalder, M. Joner, M. Kasel, S. Holdenrieder, W. Koenig, H. Schunkert, A. Kastrati, C. Hengstenberg, O. Husser (München; Valencia, ES) |